Centese
Manufacturing · Nebraska, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4156 S 52nd St, Omaha, Nebraska, 68117, ...Phone Number
(888) 220-0040Website
www.centese.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Centese
Centese specializes in innovative surgical drainage solutions, particularly through their product Thoraguard, which is designed for cardiothoracic surgery. The Thoraguard system enhances patient outcomes by providing precise data monitoring and automated chest tube clearance, addressing common issues with traditional drainage systems. Their target clients include healthcare providers in cardiac and thoracic surgery, as well as ICU and critical care teams seeking to improve workflow and patient safety. Centese is committed to reducing costs and improving recovery times through intelligent design and reliable data for clinical decision-making.Explore more
Centese Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Centese your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Centese has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Centese
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Centese had a recent Job posting/layoffs
Product Launch: Get notified when Centese launches new products
Funding: Get notified immidiatlly once Centese has new funding data
Centese, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Centese is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Centese recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Centese as Masked Content
Find 2 more new buyers
Compare Similar Companies to Centese
Compare insights from companies similar to Centese, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
1-10
Private
-
2006
DL
Dana LukinTranslational Research, Jill Roberts Center For Inflammatory Bowel Diseases Clinical Director
Company Profile Activity
Activity Insights
Centese is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Centese is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Centese.
Centese financials insights
Gather financial insights about Centese, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series B
$15M
2026
Private Equity
$250K
Centese Tech Stack
A closer look at the technologies used by Centese
Centese News & Media
Study Validates the First Automated Chest Tube Clearance System for Cardiac Surgery
Peer-reviewed clinical study shows Thoraguard® delivers effective, automated chest tube drainage following cardiac surgery Peer-reviewed clinical study shows Thoraguard® delivers effective, automated chest tube drainage following cardiac surgeryHomegrown medtech company Centese develops game-changing device for surgery patients
A new Omaha-based medtech company has developed a self-cleaning chest tube system that provides more precise measurements for monitoring patients recovering from surgery on their heart or lungs. Startup Centese developed the device, called Thoraguard. Through a novel self-irrigating mechanism, Thoraguard eliminates one of the main hazards of analog chest tubes: the need for medical… The post Homegrown medtech company Centese develops game-changing device for surgery patients appeared first on SiHomegrown medtech company Centese develops game-changing device for surgery patients
A new Omaha-based medtech company has developed a self-cleaning chest tube system that provides more precise measurements for monitoring patients recovering from surgery on their heart or lungs. Startup Centese developed the device, called Thoraguard. Through a novel self-irrigating mechanism, Thoraguard eliminates one of the main hazards of analog chest tubes: the need for medical… The post Homegrown medtech company Centese develops game-changing device for surgery patients appeared first on SiFirst Study of Thoraguard Digital Drainage System Completed at Stanford University Medical Center
OMAHA, Neb.--(BUSINESS WIRE)-- #cardiacsurgery--The first clinical study of the Thoraguard Digital Drainage System for cardiac surgery was just completed at Stanford University Medical Center.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Centese
Sign Up For FreeTo access detailed company insights
Centese specializes in innovative surgical drainage solutions, particularly through their product Thoraguard, which is designed for cardiothoracic surgery. The Thoraguard system enhances patient outcomes by providing precise data monitoring and automated chest tube clearance, addressing common issues with traditional drainage systems. Their target... Read More
